Recalls / Class I
Class ID-0332-2026
Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.
Product
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
- Affected lot / code info
- Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
Why it was recalled
CGMP Deviations: product found to contain lead.
Recalling firm
- Firm
- HANDELNINE GLOBAL LLC
- Notification channel
- Press Release
- Type
- Voluntary: Firm initiated
- Address
- South Plainfield, 4300 S Clinton Ave, South Plainfield, New Jersey 07080-1219
Distribution
- Quantity
- 4 bottles /30 capsules each
- Distribution pattern
- Product was distributed to one customer in NY.
Timeline
- Recall initiated
- 2025-12-22
- FDA classified
- 2026-02-12
- Posted by FDA
- 2026-02-11
- Status
- Ongoing
Source: openFDA Drug Enforcement endpoint. Recall record D-0332-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.